Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients

To evaluate quantitative hepatitis B surface antigen (qHBsAg) as a diagnostic marker for inactive carriers (ICs) and hepatitis B surface antigen (HBsAg) seroclearance in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients. We retrospectively studied 300 HBeAg-negative CHB patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ungtrakul, Teerapat, Sriprayoon, Tassanee, Kusuman, Pattama, Chunnuan, Pitchayachuda, Soonklang, Kamonwan, Sornsamdang, Gaidganok, Auewarakul, Chirayu U., Tanwandee, Tawesak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380303/
https://www.ncbi.nlm.nih.gov/pubmed/28353619
http://dx.doi.org/10.1097/MD.0000000000006554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380303/
https://www.ncbi.nlm.nih.gov/pubmed/28353619
http://dx.doi.org/10.1097/MD.0000000000006554

Ejemplares similares